<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01853137</url>
  </required_header>
  <id_info>
    <org_study_id>OSAMA-18-2-2013</org_study_id>
    <nct_id>NCT01853137</nct_id>
  </id_info>
  <brief_title>Fixed Lingual Mandibular Growth Modificator</brief_title>
  <acronym>FLMGM</acronym>
  <official_title>A Prospective Controlled Evaluation of Class II Division 1 Malocclusions Treated With Fixed Lingual Mandibular Growth Modificator (FLMGM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current trial was designed to investigate the possible initial net skeletal and dental&#xD;
      effects of treatment with FLMGM by a comparative evaluation of treated and untreated Cl II/1&#xD;
      malocclusion subjects. The null hypothesis stated that there were no significant differences&#xD;
      in dentofacial changes between FLMGM group and control group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was prospective controlled clinical trial conducted at the department of&#xD;
      Orthodontics, between May/2009 and June/2011. The protocol of study was approved by the&#xD;
      council of scientific research and postgraduate studies.&#xD;
&#xD;
      The original study sample included 43 patients (25 treated, 18 untreated). Of the 43 patients&#xD;
      initially enrolled, 38 completed this trial and comprised the final sample, and 5 (4 treated,&#xD;
      1 untreated) were excluded . All patients and parents gave prior informed consent to their&#xD;
      inclusion in the investigation.&#xD;
&#xD;
      Patients of both groups were followed on a parallel basis during a period of 8 months and&#xD;
      included in the trial regardless of achievement of a Class I incisor relationship. All&#xD;
      patient of treatment group (n=21) were treated with FLMGM, and treatment was continued beyond&#xD;
      this time point if the Class II malocclusion was not fully corrected and clinical objectives&#xD;
      were not achieved. On the other hand, no orthodontic treatment was performed during that&#xD;
      duration for the subjects of control group (n=17), and most of control subjects were offered&#xD;
      suitable treatment at a later date.&#xD;
&#xD;
      For each patient, a direct digital lateral cephalogram was taken pre- and post-&#xD;
      treatment/observation using PAX 400 (VATECH CO., Korea) with the same settings. Cephalograms&#xD;
      were digitized on screen and analyzed in a blind manner by the same orthodontist using a&#xD;
      cephalometric software (Viewbox, 3.1.1.13, Kifissia). . All linear measurements were reduced&#xD;
      to life size (enlargement: 7.54%).&#xD;
&#xD;
      Pretreatment equivalence, changes occurring during the examination period in each group and&#xD;
      comparison of changes observed in both groups were tested for significance with t-tests using&#xD;
      SPSS . P values of less than 0.05 were considered statistically significant. To assess the&#xD;
      method error, twenty cephalograms were randomly picked from both groups and redigitized and&#xD;
      analyzed by the same orthodontist after 1 month, and the method error was calculated by&#xD;
      Dahlberg's formula.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Mandibular Length (Co-Gn)</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overjet Reduction</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Class II Division 1 Malocclusion</condition>
  <condition>Retrognathic Mandible</condition>
  <arm_group>
    <arm_group_label>FLMGM Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Untreated Class II Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fixed Lingual Mandibular Growth Modificator (FLMGM)</intervention_name>
    <description>Novel Class II functional appliance, a fixed version of double-plate appliance</description>
    <arm_group_label>FLMGM Treatment Group</arm_group_label>
    <other_name>Fixed Lingual Mandibular Growth Modification Appliance (FLMGMA)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Before treatment, each patient fulfilled the following criteria:&#xD;
&#xD;
          1. Cl II/1 malocclusion with an overjet greater than 4 mm.&#xD;
&#xD;
          2. Mild to moderate Class II Skeletal pattern (A-N-B &gt; 4°) with retrognathic mandible&#xD;
             (S-N-B &lt; 76°).&#xD;
&#xD;
          3. Growth potential. Fishman skeletal maturation indicator (SMI) method28 was used to&#xD;
             assess the hand-wrist radiographs, and only patients in the peak of the pubertal&#xD;
             growth spurt, which occurs on average between SMIs 4 to 7,29 at the beginning of the&#xD;
             treatment/observation period were invited.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Osama H Alali, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior Lecturer, Department of Orthodontics, School of Dentistry, University of Aleppo, Syria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Orthodontics, School of Dentistry, University of Damascus</name>
      <address>
        <city>Damascus</city>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 10, 2013</study_first_submitted>
  <study_first_submitted_qc>May 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2013</study_first_posted>
  <results_first_submitted>May 14, 2013</results_first_submitted>
  <results_first_submitted_qc>October 20, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 12, 2020</results_first_posted>
  <last_update_submitted>October 20, 2020</last_update_submitted>
  <last_update_submitted_qc>October 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Class II division 1 malocclusion</keyword>
  <keyword>Dentofacial orthopedics</keyword>
  <keyword>Fixed Lingual Mandibular Growth Modificator (FLMGM)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malocclusion</mesh_term>
    <mesh_term>Malocclusion, Angle Class II</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>patients were recruited from those referred to the department of Orthodontics at the University of Damascus between May 2009 and June 2011.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>FLMGM Treatment Group</title>
          <description>Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance</description>
        </group>
        <group group_id="P2">
          <title>Untreated Class II Control Group</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Using Bland formula (1995)</population>
      <group_list>
        <group group_id="B1">
          <title>FLMGM Treatment Group</title>
          <description>Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance</description>
        </group>
        <group group_id="B2">
          <title>Untreated Class II Control Group</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.2" spread="0.9"/>
                    <measurement group_id="B2" value="12.5" spread="2.1"/>
                    <measurement group_id="B3" value="13.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Syrian Arab Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Mandibular Length (Co-Gn)</title>
        <time_frame>8 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>FLMGM Treatment Group</title>
            <description>Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance</description>
          </group>
          <group group_id="O2">
            <title>Untreated Class II Control Group</title>
            <description>This is a group of patients classified as Class II patients but they are not treated during the observation period of this study</description>
          </group>
        </group_list>
        <measure>
          <title>Total Mandibular Length (Co-Gn)</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.51" spread="1.37"/>
                    <measurement group_id="O2" value="1.18" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overjet Reduction</title>
        <time_frame>8 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>FLMGM Treatment Group</title>
            <description>Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance</description>
          </group>
          <group group_id="O2">
            <title>Untreated Class II Control Group</title>
          </group>
        </group_list>
        <measure>
          <title>Overjet Reduction</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.32" spread="2.86"/>
                    <measurement group_id="O2" value="0.74" spread="0.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>FLMGM Treatment Group</title>
          <description>Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance</description>
        </group>
        <group group_id="E2">
          <title>Untreated Class II Control Group</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr.</name_or_title>
      <organization>Osama AlAli</organization>
      <phone>00963992262582</phone>
      <email>osama-alali@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

